
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
TREM-2 defends the liver against hepatocellular carcinoma through multifactorial protective mechanisms
Aitor Esparza-Baquer, Ibone Labiano, Omar Sharif, et al.
Gut (2020) Vol. 70, Iss. 7, pp. 1345-1361
Open Access | Times Cited: 93
Aitor Esparza-Baquer, Ibone Labiano, Omar Sharif, et al.
Gut (2020) Vol. 70, Iss. 7, pp. 1345-1361
Open Access | Times Cited: 93
Showing 1-25 of 93 citing articles:
Macrophages in health and disease
Matthew D. Park, Aymeric Silvin, Florent Ginhoux, et al.
Cell (2022) Vol. 185, Iss. 23, pp. 4259-4279
Open Access | Times Cited: 340
Matthew D. Park, Aymeric Silvin, Florent Ginhoux, et al.
Cell (2022) Vol. 185, Iss. 23, pp. 4259-4279
Open Access | Times Cited: 340
The biology of TREM receptors
Marco Colonna
Nature reviews. Immunology (2023) Vol. 23, Iss. 9, pp. 580-594
Open Access | Times Cited: 187
Marco Colonna
Nature reviews. Immunology (2023) Vol. 23, Iss. 9, pp. 580-594
Open Access | Times Cited: 187
Identification of a broadly fibrogenic macrophage subset induced by type 3 inflammation
Thomas Fabre, Alex Barron, Stephen M. Christensen, et al.
Science Immunology (2023) Vol. 8, Iss. 82
Closed Access | Times Cited: 152
Thomas Fabre, Alex Barron, Stephen M. Christensen, et al.
Science Immunology (2023) Vol. 8, Iss. 82
Closed Access | Times Cited: 152
Prolonged hypernutrition impairs TREM2-dependent efferocytosis to license chronic liver inflammation and NASH development
Xiaochen Wang, Qifeng He, Chuanli Zhou, et al.
Immunity (2022) Vol. 56, Iss. 1, pp. 58-77.e11
Open Access | Times Cited: 118
Xiaochen Wang, Qifeng He, Chuanli Zhou, et al.
Immunity (2022) Vol. 56, Iss. 1, pp. 58-77.e11
Open Access | Times Cited: 118
TREM2 macrophages drive NK cell paucity and dysfunction in lung cancer
Matthew D. Park, Ivan Reyes-Torres, Jessica LeBérichel, et al.
Nature Immunology (2023) Vol. 24, Iss. 5, pp. 792-801
Closed Access | Times Cited: 116
Matthew D. Park, Ivan Reyes-Torres, Jessica LeBérichel, et al.
Nature Immunology (2023) Vol. 24, Iss. 5, pp. 792-801
Closed Access | Times Cited: 116
An adipocentric perspective on the development and progression of non-alcoholic fatty liver disease
Eun Young Lee, Hannelie Korf, Antonio Vidal‐Puig
Journal of Hepatology (2023) Vol. 78, Iss. 5, pp. 1048-1062
Open Access | Times Cited: 104
Eun Young Lee, Hannelie Korf, Antonio Vidal‐Puig
Journal of Hepatology (2023) Vol. 78, Iss. 5, pp. 1048-1062
Open Access | Times Cited: 104
TREM2 inhibition triggers antitumor cell activity of myeloid cells in glioblastoma
Rui Sun, Rowland H. Han, Colin McCornack, et al.
Science Advances (2023) Vol. 9, Iss. 19
Open Access | Times Cited: 52
Rui Sun, Rowland H. Han, Colin McCornack, et al.
Science Advances (2023) Vol. 9, Iss. 19
Open Access | Times Cited: 52
Molecular mechanisms in MASLD/MASH-related HCC
Xiaobo Wang, Liang Zhang, Bingning Dong
Hepatology (2024)
Closed Access | Times Cited: 45
Xiaobo Wang, Liang Zhang, Bingning Dong
Hepatology (2024)
Closed Access | Times Cited: 45
Spatially restricted and ontogenically distinct hepatic macrophages are required for tissue repair
Federico F. De Ponti, Anna Bujko, Zhuangzhuang Liu, et al.
Immunity (2025)
Open Access | Times Cited: 4
Federico F. De Ponti, Anna Bujko, Zhuangzhuang Liu, et al.
Immunity (2025)
Open Access | Times Cited: 4
Parkin modulates the hepatocellular carcinoma microenvironment by regulating PD-1/PD-L1 signalling
Guiqin Ye, Xin Sun, Jiuzhou Li, et al.
Journal of Advanced Research (2025)
Open Access | Times Cited: 3
Guiqin Ye, Xin Sun, Jiuzhou Li, et al.
Journal of Advanced Research (2025)
Open Access | Times Cited: 3
Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker
Xin Cheng, Xiaowei Wang, Kechao Nie, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 91
Xin Cheng, Xiaowei Wang, Kechao Nie, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 91
Immunosuppressive TREM2(+) macrophages are associated with undesirable prognosis and responses to anti-PD-1 immunotherapy in non-small cell lung cancer
Hongyu Zhang, Zilong Liu, Haoyu Wen, et al.
Cancer Immunology Immunotherapy (2022) Vol. 71, Iss. 10, pp. 2511-2522
Closed Access | Times Cited: 67
Hongyu Zhang, Zilong Liu, Haoyu Wen, et al.
Cancer Immunology Immunotherapy (2022) Vol. 71, Iss. 10, pp. 2511-2522
Closed Access | Times Cited: 67
Integrated Analysis Highlights the Immunosuppressive Role of TREM2+ Macrophages in Hepatocellular Carcinoma
Lisha Zhou, Meiling Wang, Hanrui Guo, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 65
Lisha Zhou, Meiling Wang, Hanrui Guo, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 65
TREM-2 plays a protective role in cholestasis by acting as a negative regulator of inflammation
Ibone Labiano, Aloña Agirre‐Lizaso, Paula Olaizola, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 4, pp. 991-1004
Open Access | Times Cited: 47
Ibone Labiano, Aloña Agirre‐Lizaso, Paula Olaizola, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 4, pp. 991-1004
Open Access | Times Cited: 47
Targeting of GSDMD sensitizes HCC to anti-PD-1 by activating cGAS pathway and downregulating PD-L1 expression
Tingting Lv, Xiaofeng Xiong, Wei Yan, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 6, pp. e004763-e004763
Open Access | Times Cited: 44
Tingting Lv, Xiaofeng Xiong, Wei Yan, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 6, pp. e004763-e004763
Open Access | Times Cited: 44
Exploring the Impact of TREM2 in Tumor-Associated Macrophages
Darya Khantakova, Simone Brioschi, Martina Molgora
Vaccines (2022) Vol. 10, Iss. 6, pp. 943-943
Open Access | Times Cited: 40
Darya Khantakova, Simone Brioschi, Martina Molgora
Vaccines (2022) Vol. 10, Iss. 6, pp. 943-943
Open Access | Times Cited: 40
The microglial innate immune receptors TREM-1 and TREM-2 in the anterior cingulate cortex (ACC) drive visceral hypersensitivity and depressive-like behaviors following DSS-induced colitis
Ke Wu, Yue-Ying Liu, Shuai Shao, et al.
Brain Behavior and Immunity (2023) Vol. 112, pp. 96-117
Closed Access | Times Cited: 33
Ke Wu, Yue-Ying Liu, Shuai Shao, et al.
Brain Behavior and Immunity (2023) Vol. 112, pp. 96-117
Closed Access | Times Cited: 33
TREM2: A new player in the tumor microenvironment
Martina Molgora, Yizhou Liu, Marco Colonna, et al.
Seminars in Immunology (2023) Vol. 67, pp. 101739-101739
Open Access | Times Cited: 30
Martina Molgora, Yizhou Liu, Marco Colonna, et al.
Seminars in Immunology (2023) Vol. 67, pp. 101739-101739
Open Access | Times Cited: 30
TREM2 Insufficiency Protects against Pulmonary Fibrosis by Inhibiting M2 Macrophage Polarization
Qiujie Luo, Dawei Deng, Li Yang, et al.
International Immunopharmacology (2023) Vol. 118, pp. 110070-110070
Open Access | Times Cited: 25
Qiujie Luo, Dawei Deng, Li Yang, et al.
International Immunopharmacology (2023) Vol. 118, pp. 110070-110070
Open Access | Times Cited: 25
TREM2 is associated with tumor immunity and implies poor prognosis in glioma
Mingchen Yu, Yuanhao Chang, You Zhai, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 23
Mingchen Yu, Yuanhao Chang, You Zhai, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 23
Distinct roles of TREM2 in central nervous system cancers and peripheral cancers
Jian Zhong, Xudong Xing, Yixin Gao, et al.
Cancer Cell (2024) Vol. 42, Iss. 6, pp. 968-984.e9
Closed Access | Times Cited: 12
Jian Zhong, Xudong Xing, Yixin Gao, et al.
Cancer Cell (2024) Vol. 42, Iss. 6, pp. 968-984.e9
Closed Access | Times Cited: 12
Deciphering the molecular and clinical characteristics of TREM2, HCST, and TYROBP in cancer immunity: A comprehensive pan-cancer study
Piao Zheng, Yejun Tan, Qing Liu, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e26993-e26993
Open Access | Times Cited: 11
Piao Zheng, Yejun Tan, Qing Liu, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e26993-e26993
Open Access | Times Cited: 11
Myeloid Trem2 ameliorates the progression of metabolic dysfunction-associated steatotic liver disease by regulating macrophage pyroptosis and inflammation resolution
Wenjie Yu, Yu Zhang, Linfeng Sun, et al.
Metabolism (2024) Vol. 155, pp. 155911-155911
Open Access | Times Cited: 10
Wenjie Yu, Yu Zhang, Linfeng Sun, et al.
Metabolism (2024) Vol. 155, pp. 155911-155911
Open Access | Times Cited: 10
Tumor-associated macrophages in cholangiocarcinoma: complex interplay and potential therapeutic target
Menghua Zhou, Chaoqun Wang, Shounan Lu, et al.
EBioMedicine (2021) Vol. 67, pp. 103375-103375
Open Access | Times Cited: 54
Menghua Zhou, Chaoqun Wang, Shounan Lu, et al.
EBioMedicine (2021) Vol. 67, pp. 103375-103375
Open Access | Times Cited: 54
Trem-2 Promotes Emergence of Restorative Macrophages and Endothelial Cells During Recovery From Hepatic Tissue Damage
Inês Coelho, Nádia Duarte, André Barros, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 51
Inês Coelho, Nádia Duarte, André Barros, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 51